These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24967815)

  • 1. Detection of 3,5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody-based chemiluminescence immunoassay.
    Lehmphul I; Brabant G; Wallaschofski H; Ruchala M; Strasburger CJ; Köhrle J; Wu Z
    Thyroid; 2014 Sep; 24(9):1350-60. PubMed ID: 24967815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of 3, 3'-diiodothyronine, 3', 5'-diiodothyronine, and 3, 5-diiodothyronine in altered thyroid states.
    Nishikawa M; Inada M; Naito K; Ishii H; Tanaka K; Mashio Y; Imura H
    Endocrinol Jpn; 1983 Apr; 30(2):167-72. PubMed ID: 6641638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'-5'-Diiodothyronine in health and disease: studies by a radioimmunoassay.
    Chopra IJ; Geola F; Solomon DH; Maciel RM
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1198-207. PubMed ID: 263734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay.
    Hoefig CS; Köhrle J; Brabant G; Dixit K; Yap B; Strasburger CJ; Wu Z
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1864-72. PubMed ID: 21490071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,3'-Diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors and of healthy subjects during acute stress.
    Pinna G; Hiedra L; Meinhold H; Eravci M; Prengel H; Brödel O; Gräf KJ; Stoltenburg-Didinger G; Bauer M; Baumgartner A
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3071-7. PubMed ID: 9745405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating pharmacological findings from hypothyroid rodents to euthyroid humans: is there a functional role of endogenous 3,5-T2?
    Pietzner M; Lehmphul I; Friedrich N; Schurmann C; Ittermann T; Dörr M; Nauck M; Laqua R; Völker U; Brabant G; Völzke H; Köhrle J; Homuth G; Wallaschofski H
    Thyroid; 2015 Feb; 25(2):188-97. PubMed ID: 25343227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors.
    Pinna G; Meinhold H; Hiedra L; Thoma R; Hoell T; Gräf KJ; Stoltenburg-Didinger G; Eravci M; Prengel H; Brödel O; Finke R; Baumgartner A
    J Clin Endocrinol Metab; 1997 May; 82(5):1535-42. PubMed ID: 9141546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous measurement of 3,5-diiodothyronine and 3,5,3'-triiodothyronine turnover kinetics in euthyroid hyperthyroid, and hypothyroid subjects.
    Faber J; Kirkegaard C; Lumholtz IB; Siersbaek-Nielsen K; Friis T
    J Clin Endocrinol Metab; 1982 Jul; 55(1):8-12. PubMed ID: 7076809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, and 3',5'-diiodothyronine in man.
    Faber J; Lumholtz IB; Kirkegaard C; Poulsen S; Jørgensen PH; Siersbaek-Nielsen K; Friis T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1093-9. PubMed ID: 4055984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,5-T2-A Janus-Faced Thyroid Hormone Metabolite Exerts Both Canonical T3-Mimetic Endocrine and Intracrine Hepatic Action.
    Köhrle J; Lehmphul I; Pietzner M; Renko K; Rijntjes E; Richards K; Anselmo J; Danielsen M; Jonklaas J
    Front Endocrinol (Lausanne); 2019; 10():787. PubMed ID: 31969860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Thyroid Hormone-Independent Molecular Fingerprint of 3,5-Diiodothyronine Suggests a Strong Relationship with Coffee Metabolism in Humans.
    Pietzner M; Köhrle J; Lehmphul I; Budde K; Kastenmüller G; Brabant G; Völzke H; Artati A; Adamski J; Völker U; Nauck M; Friedrich N; Homuth G
    Thyroid; 2019 Dec; 29(12):1743-1754. PubMed ID: 31571530
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of thyroid hormones in placenta using isotope-dilution liquid chromatography quadrupole time-of-flight mass spectrometry.
    Li ZM; Giesert F; Vogt-Weisenhorn D; Main KM; Skakkebæk NE; Kiviranta H; Toppari J; Feldt-Rasmussen U; Shen H; Schramm KW; De Angelis M
    J Chromatogr A; 2018 Jan; 1534():85-92. PubMed ID: 29307529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in Thyroid Hormone Metabolite Concentrations Across Different Thyroid States.
    Jongejan RMS; van Velsen EFS; Meima ME; Klein T; van den Berg SAA; Massolt ET; Visser WE; Peeters RP; de Rijke YB
    Thyroid; 2022 Feb; 32(2):119-127. PubMed ID: 34806412
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic studies of thyroxine, 3,5,3'-triiodothyronine, 3,3,5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine in patients with liver cirrhosis.
    Faber J; Thomsen HF; Lumholtz IB; Kirkegaard C; Siersbaek-Nielsen K; Friis T
    J Clin Endocrinol Metab; 1981 Nov; 53(5):978-84. PubMed ID: 7287881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating 3-T1AM and 3,5-T2 in Critically Ill Patients: A Cross-Sectional Observational Study.
    Langouche L; Lehmphul I; Perre SV; Köhrle J; Van den Berghe G
    Thyroid; 2016 Dec; 26(12):1674-1680. PubMed ID: 27676423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes of serum 3,3'-diiodothyronine, 3',5'-diiodothyronine, and 3,5-diiodothyronine concentrations in man.
    Nishikawa M; Inada M; Naito K; Ishii H; Tanaka K; Mashio Y; Imura H
    J Clin Endocrinol Metab; 1981 Mar; 52(3):517-22. PubMed ID: 7462404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radioimmunoassay for 3',5'-diiodothyronine.
    Burman KD; Wright FD; Smallridge RC; Green BJ; Georges LP; Wartofsky L
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1059-64. PubMed ID: 263335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical value comparison between chemiluminescent immunoassay and immunoradiometric assay in detecting TSH in serum].
    Yu JY; Lin Y
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):275-7. PubMed ID: 14653089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.
    Fisher DA; Schoen EJ; La Franchi S; Mandel SH; Nelson JC; Carlton EI; Goshi JH
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2722-7. PubMed ID: 10946871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.